Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Journal Article (Journal Article)

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

Full Text

Duke Authors

Cited Authors

  • Ajani, JA; D'Amico, TA; Almhanna, K; Bentrem, DJ; Chao, J; Das, P; Denlinger, CS; Fanta, P; Farjah, F; Fuchs, CS; Gerdes, H; Gibson, M; Glasgow, RE; Hayman, JA; Hochwald, S; Hofstetter, WL; Ilson, DH; Jaroszewski, D; Johung, KL; Keswani, RN; Kleinberg, LR; Korn, WM; Leong, S; Linn, C; Lockhart, AC; Ly, QP; Mulcahy, MF; Orringer, MB; Perry, KA; Poultsides, GA; Scott, WJ; Strong, VE; Washington, MK; Weksler, B; Willett, CG; Wright, CD; Zelman, D; McMillian, N; Sundar, H

Published Date

  • October 2016

Published In

Volume / Issue

  • 14 / 10

Start / End Page

  • 1286 - 1312

PubMed ID

  • 27697982

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2016.0137


  • eng

Conference Location

  • United States